Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of Transcutaneous Bilirubin Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants: a Multicenter Study in China

NCT01763632 is registered in ClinicalTrials.gov with Nanjing Medical University as lead sponsor.

NCT NCT01763632
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01763632 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of Transcutaneous Bilirubin Nomogram to Identify Neonatal Hyperbilirubinemia in Term and Late-preterm Infants: a Multicenter Study in China
Lead sponsor
Nanjing Medical University
Phase
Observational
Overall status
Completed
Start date
January 31, 2013
Completion date
December 31, 2013
Enrollment
19,601 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

hyperbilirubinemia, neonatal